Related references
Note: Only part of the references are listed.Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology
Marco Gessi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Integrated molecular characterization of IDH-mutant glioblastomas
A. Korshunov et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Mitsuaki Shirahata et al.
ACTA NEUROPATHOLOGICA (2018)
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
David Capper et al.
ACTA NEUROPATHOLOGICA (2018)
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations
Annekathrin Reinhardt et al.
ACTA NEUROPATHOLOGICA (2018)
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
Maximilian Y. Deng et al.
ACTA NEUROPATHOLOGICA (2018)
Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information
Christian Koelsche et al.
MODERN PATHOLOGY (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma
Damian Stichel et al.
ACTA NEUROPATHOLOGICA (2018)
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
Kristian W. Pajtler et al.
ACTA NEUROPATHOLOGICA (2017)
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Edward C. Schwalbe et al.
LANCET ONCOLOGY (2017)
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
Felix Sahm et al.
LANCET ONCOLOGY (2017)
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
John C. DeWitt et al.
NEURO-ONCOLOGY (2017)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Methylation-based classification of benign and malignant peripheral nerve sheath tumors
Manuel Roehrich et al.
ACTA NEUROPATHOLOGICA (2016)
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
Ibrahim Qaddoumi et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Dominik Sturm et al.
CELL (2016)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
Kristian W. Pajtler et al.
CANCER CELL (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
Heather E. Leeper et al.
ONCOTARGET (2015)
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an integrated diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma
Benedikt Wiestler et al.
ACTA NEUROPATHOLOGICA (2014)
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma
Felix Sahm et al.
ACTA NEUROPATHOLOGICA (2014)
What do we know about IDH1/2 mutations so far, and how do we use it?
Craig Horbinski
ACTA NEUROPATHOLOGICA (2013)
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
Volker Hovestadt et al.
ACTA NEUROPATHOLOGICA (2013)
A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)
Rikke H. Dahlrot et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
Xiao-Yang Liu et al.
ACTA NEUROPATHOLOGICA (2012)
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
Dong-Anh Khuong-Quang et al.
ACTA NEUROPATHOLOGICA (2012)
A DNA methylation fingerprint of 1628 human samples
Agustin F. Fernandez et al.
GENOME RESEARCH (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Genevieve Schindler et al.
ACTA NEUROPATHOLOGICA (2011)
IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee
M. Preusser et al.
CLINICAL NEUROPATHOLOGY (2011)
Monoclonal antibody specific for IDH1 R132H mutation
David Capper et al.
ACTA NEUROPATHOLOGICA (2009)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Sumihito Nobusawa et al.
CLINICAL CANCER RESEARCH (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Share Paper
